Actively Recruiting
Promotion of Vaginal Health With CH2 Vaginal Gel After Pelvic Radiotherapy
Led by National Taiwan University Hospital · Updated on 2025-06-27
60
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective clinical trial planning to enroll female patients who have completed pelvic radiotherapy. Participants will undergo a 12-week intervention with either CH2 vaginal gel or vaginal rehabilitation exercises. The primary endpoint is the change in the Female Sexual Function Index scores.
CONDITIONS
Official Title
Promotion of Vaginal Health With CH2 Vaginal Gel After Pelvic Radiotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients aged between 20 and 70 years
- Completion of pelvic radiotherapy for gynecologic cancer including external beam radiotherapy, brachytherapy, or both
- Eastern Cooperative Oncology Group (ECOG) performance status score of 0-1
You will not qualify if you...
- Individuals under 18 years of age
- Presence of distant metastases or history of malignancy under treatment within past 5 years excluding non-melanoma skin cancer
- Severe comorbidities such as uncontrolled diabetes, cardiovascular disease, or autoimmune disorders
- Diagnosed psychiatric disorders or social factors preventing adherence or follow-up
- Inability to self-administer vaginal gel or vaginal rehabilitation exercises
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Taiwan University Cancer Center
Taipei, Taiwan
Actively Recruiting
Research Team
J
Jenny Ling-Yu Chen Professor, Attending Physician, MD PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here